NCT00750308View on ClinicalTrials.gov

Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi and PE5i

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

May 31, 2009

Conditions
Metabolic Syndrome
Interventions
DRUG

Ramipril

Ramipril 10 mg per day for three weeks

DRUG

Tadalafil

tadalafil 10 mg every other day for three weeks

DRUG

placebo

placebo matching ramipril

DRUG

placebo

placebo matching tadalafil

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Vanderbilt University

OTHER

NCT00750308 - Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi and PE5i | Biotech Hunter | Biotech Hunter